Recursion Pharmaceuticals Inc (RXRX)
9.51
-0.50
(-5.00%)
USD |
NASDAQ |
May 16, 16:00
9.51
0.00 (0.00%)
After-Hours: 20:00
Recursion Pharmaceuticals Price to Book Value: 5.634 for May 16, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 5.634 |
| May 15, 2024 | 5.930 |
| May 14, 2024 | 5.954 |
| May 13, 2024 | 5.616 |
| May 10, 2024 | 5.095 |
| May 09, 2024 | 5.119 |
| May 08, 2024 | 5.089 |
| May 07, 2024 | 5.208 |
| May 06, 2024 | 5.296 |
| May 03, 2024 | 5.237 |
| May 02, 2024 | 5.208 |
| May 01, 2024 | 4.941 |
| April 30, 2024 | 4.633 |
| April 29, 2024 | 4.855 |
| April 26, 2024 | 4.808 |
| April 25, 2024 | 4.642 |
| April 24, 2024 | 4.701 |
| April 23, 2024 | 4.559 |
| April 22, 2024 | 4.50 |
| April 19, 2024 | 4.352 |
| April 18, 2024 | 4.382 |
| April 17, 2024 | 4.423 |
| April 16, 2024 | 4.482 |
| April 15, 2024 | 4.612 |
| April 12, 2024 | 4.980 |
| Date | Value |
|---|---|
| April 11, 2024 | 5.281 |
| April 10, 2024 | 5.080 |
| April 09, 2024 | 5.382 |
| April 08, 2024 | 5.329 |
| April 05, 2024 | 5.252 |
| April 04, 2024 | 5.169 |
| April 03, 2024 | 5.287 |
| April 02, 2024 | 5.192 |
| April 01, 2024 | 5.548 |
| March 31, 2024 | |
| March 28, 2024 | 5.048 |
| March 27, 2024 | 5.149 |
| March 26, 2024 | 5.225 |
| March 25, 2024 | 5.332 |
| March 22, 2024 | 5.311 |
| March 21, 2024 | 5.392 |
| March 20, 2024 | 5.605 |
| March 19, 2024 | 5.443 |
| March 18, 2024 | 5.782 |
| March 15, 2024 | 5.681 |
| March 14, 2024 | 5.458 |
| March 13, 2024 | 5.560 |
| March 12, 2024 | 5.337 |
| March 11, 2024 | 5.251 |
| March 08, 2024 | 5.666 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.756
Minimum
May 11 2022
10.83
Maximum
Jul 13 2021
4.320
Average
4.094
Median
Nov 28 2022
Price to Book Value Benchmarks
| Eli Lilly and Co | 57.20 |
| Absci Corp | 2.232 |
| Palatin Technologies Inc | -- |
| Oragenics Inc | 4.636 |
| Actinium Pharmaceuticals Inc | 6.618 |
Price to Book Value Related Metrics
| PS Ratio | 45.93 |
| PEG Ratio | -0.3375 |
| Price | 9.51 |
| Earnings Yield | -17.03% |
| Market Cap | 2.260B |
| PEGY Ratio | -0.3375 |